Focus on Lipids Care

Back to articles

Statins and the High-Risk Elderly: Pravastatin Safe and Well Tolerated

KEY POINT

Results of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) extend the health benefits of statins into the elderly patient population.

SOURCES

Shepherd J et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623–30.

Collins R, Armitage J. High-risk elderly patients PROSPER from cholesterol-lowering therapy [editorial]. Lancet. 2002;360:1618–9.